Navigation Links
Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
Date:1/10/2011

excreted in human milk, caution should be exercised when KAPVAY™ is administered to a nursing woman.

Caution is warranted in patients receiving clonidine concomitantly with agents known to affect sinus node function or AV nodal conduction (e.g., digitalis, calcium channel blockers and beta-blockers) due to a potential for additive effects such as bradycardia and AV block.

Clonidine, the active ingredient in KAPVAY™, is also approved as an antihypertensive.  Do not use KAPVAY™ in patients concomitantly taking other clonidine-containing products, (e.g. Catapres®, JENLOGA, etc.).

Common adverse reactions (incidence at least 5% and twice the rate of placebo) include:

Somnolence, fatigue, upper respiratory tract infection, irritability, throat pain, insomnia, nightmares, emotional disorder, constipation, nasal congestion, increased body temperature, dry mouth, and ear pain.

To report SUSPECTED ADVERSE REACTIONS, contact Shionogi Pharma, Inc. at 1-800-849-9707 ext. 1454 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

For full prescribing information, please visit www.KAPVAY.com.  

About ADHD

ADHD is a neurobehavioral disorder that most often occurs in childhood and may continue into adolescence and adulthood. There are three subtypes of ADHD: predominantly hyperactive-impulsive, predominantly inattentive, and combined hyperactive-impulsive and inattentive, with the latter being the most common. ADHD symptoms fall under three main categories: inattention, hyperactivity and impulsivity, which can include behaviors such as trouble focusing, frequent daydreaming, excessive talking, fidgeting/squirming, chronic impatience and difficulty waiting their turn, depending on the category.

The cause of ADHD is not yet known. However, research has shown potential links to genetic and environmental fac
'/>"/>

SOURCE Shionogi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
2. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
3. BioCrysts Partner Shionogi Launches Peramivir In Japan Under The Name RAPIACTA
4. Shionogi Enters Into Exclusive License Agreement With QuatRx Pharmaceuticals To Market Ospemifene
5. Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
6. Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization of ... it will present at the Barclays Global Healthcare ... the Loews Miami Beach Hotel in Miami ... Peter , M.D., President and Chief Executive Officer of ...
(Date:3/4/2015)... , March 4, 2015  Bayer HealthCare today ... (FDA) has accepted the company,s Biologics License Application ... compound.  Bayer is seeking FDA approval of the ... treatment of hemophilia A in children and adults. ... bringing new therapies to hemophilia A patients who ...
(Date:3/4/2015)... -- Halyard Health, Inc. (NYSE: HYH ) today ... and related key planning assumptions. "This is ... our fourth quarter results, our first as an independent ... a smooth separation from Kimberly-Clark and I,m pleased with ... growth and margin improvement in the fourth quarter while ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31
(Date:3/4/2015)... (PRWEB) March 04, 2015 Blake’s ... frozen food category, will attend this year’s Natural Products ... newest product line. With this new line, Blake’s, who ... the natural channel, continues its commitment to creating high-quality ... growing frozen brand in the natural channel, Blake’s understands ...
(Date:3/4/2015)... Vancouver chiropractic clinic, Backs in Action ... the prestigious Vancouver Courier “Stars of Vancouver” 2015 ... company secured third place in the “Best Chiropractor” ... Massage Therapist” category. , As one of ... Vancouver Courier is a semiweekly local newspaper published ...
(Date:3/4/2015)... " Optrix by Body Glove ” was featured ... which takes a look at the latest and coolest ... a special reporter for NewsWatch and a technology expert, ... they have an ultra-rugged, waterproof case with an interchangeable ... player at the Consumer Electronics Show in Las Vegas ...
(Date:3/4/2015)... The Global Liquefied Petroleum Gas ... and is estimated to grow to $288.7 billion ... 2014 to 2019. , Browse through the TOC ... analysis of industry trends, segments & forecasts., ... gas market is classified into source, application, and ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Organic Valley, the ... brand, today announced its cause campaign to Save the Bros, ... and is making a difference to Bros everywhere. To ... Youtube and Facebook. The video was named Adweek’s best ... in Forbes, Mashable and Digiday, among other media outlets. ...
Breaking Medicine News(10 mins):Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3
... Newly Passed Legislation Recognizes Critical Care Needs of ... The Council for Quality,Respiratory Care (CQRC), an ... providers and manufacturers representing nearly one half of,Medicare,s ... passing,the House,s Medicare package (HR. 6331), which protects ...
... redcrossracing.com, WASHINGTON, July 10 3M Company and ... efforts,throughout the Central United States by providing the Red ... 3M and NASCAR Sprint Cup driver Greg Biffle ... support Red Cross disaster relief,efforts through on-track visibility. This ...
... Health estimates that in any given year, about ,40 ... form of anxiety disorder, including debilitating conditions such as ... It is estimated that nearly 15 percent of U.S. ... the urgency to develop better treatment strategies for anxiety ...
... global,provider of medical imaging and fusion software, announced the ... application for,iPhone and iPod touch on the Apple App ... doctor or patient to view medical,images remotely, without access ... with her patient, sharing images with him,iPhone to iPhone, ...
... restaurant during the breakfast rush the clang of plates ... the crucial test of new hearing aid technology in a ... in St. Louis. The study showed that the hearing aids ... test for a hearing aid. ,But the patients wearing the ...
... May Contribute to Failure Rate, ... Authors Say, ... (ACL) tears happening each year in the United,States (Source: American Journal of ... the best,replacement ligament for surgery is one key to success. A study ...
Cached Medicine News:Health News:Home Oxygen Care Leaders Applaud U.S. Senate for Passing Medicare Bill to Improve and Protect Home Oxygen Benefit 2Health News:Red Cross NASCAR Partners Rally to Support Relief Efforts 2Health News:Red Cross NASCAR Partners Rally to Support Relief Efforts 3Health News:Red Cross NASCAR Partners Rally to Support Relief Efforts 4Health News:Red Cross NASCAR Partners Rally to Support Relief Efforts 5Health News:Rutgers research identifies brain cells related to fear 2Health News:Rutgers research identifies brain cells related to fear 3Health News:MIM for the iPhone Is Available Free From the Apple App Store 2Health News:New hearing aid technology passes the restaurant noise test 2Health News:New hearing aid technology passes the restaurant noise test 3Health News:New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients 2
... Billing offers a set of features for ... Windows-based design that allows staff to customize ... preferences. Using Medical Billing's electronic encounter forms, ... point of care when used with Practice ...
... environment, providers can code the charge while completing ... PDA while away from office, both directly feeding ... use an Encounter Form/Superbill, data entry can be ... and patient payments are posted by reflecting open ...
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
Medicine Products: